Brief: Inventiva SA - To Focus On Lanifibranor, Stop Preclinical Research, Reduce Workforce By 50%
10/02/2025 21:31
Inventiva SA IVAA.PA :
* INVENTIVA SA - TO FOCUS ON LANIFIBRANOR, STOP PRECLINICAL
RESEARCH, REDUCE WORKFORCE BY 50%
* INVENTIVA SA: DOES NOT HAVE SUFFICIENT NET WORKING CAPITAL
TO
MEET ITS CURRENT OBLIGATIONS OVER NEXT 12 MONTHS
Source text: ID:nGNXbmdcVk
Further company coverage: IVAA.PA
Recent news on Inventiva SA
See all newsFrance's Inventiva H1 net loss narrows
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Inventiva Announces Last Patient Visit In Nativ3 Phase 3 Clinical Trial Of Lanifibranor In Mash
Brief: Inventiva Announces Comprehensive Capital Structure Optimization Including Debt And Equity Financing In Advance Of The Anticipated Phase 3 Readout
Brief: Inventiva Secures Up To €150 Mln Debt Financing, Extends Debt Maturity To 2030